Type 2 diabetic (T2D) patients taking sulfonylureas are at an increased risk of hypoglycemia (2.5x) compared to metformin users. T2D patients taking sulfonylureas with severe renal impairment (GFR 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback